-
1
المؤلفون: Ukhyun Jo, Yasuhisa Murai, Keli K. Agama, Yilun Sun, Liton Kumar Saha, Xi Yang, Yasuhiro Arakawa, Sophia Gayle, Kelli Jones, Vishwas Paralkar, Ranjini K. Sundaram, Jinny Van Doorn, Juan C. Vasquez, Ranjit S. Bindra, Woo Suk Choi, Yves Pommier
المصدر: Mol Cancer Ther
مصطلحات موضوعية: Cancer Research, Nuclear Proteins, Ataxia Telangiectasia Mutated Proteins, DNA, Article, Mice, Oncology, DNA Topoisomerases, Type I, Neoplasms, Animals, Humans, Camptothecin, Topoisomerase I Inhibitors, Protein Kinase Inhibitors
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6466f0700aba495f0651048d49ff2da
https://europepmc.org/articles/PMC9256811/ -
2
المؤلفون: Florence Gattacceca, Alexandre Evrard, Marc Ychou, Laure Deyme, Dominique Barbolosi, Nicole Tubiana-Mathieu, Litaty Mbatchi
المساهمون: Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (COMPO), Inria Sophia Antipolis - Méditerranée (CRISAM), Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), CHU Limoges, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), GATTACCECA, Florence
المصدر: Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, 2021, 88 (2), pp.247-258. ⟨10.1007/s00280-021-04255-9⟩
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2021, 88 (2), pp.247-258. ⟨10.1007/s00280-021-04255-9⟩مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, FOLFIRINOX, Leucovorin, Toxicology, 0302 clinical medicine, CPT-11, Antineoplastic Combined Chemotherapy Protocols, Pharmacology (medical), Population pharmacokinetics, ComputingMilieux_MISCELLANEOUS, education.field_of_study, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, [SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences, Oxaliplatin, 030220 oncology & carcinogenesis, FOLFIRI, Female, Fluorouracil, Folfirinox Regimen, Colorectal Neoplasms, medicine.drug, medicine.medical_specialty, Population, [SDV.CAN]Life Sciences [q-bio]/Cancer, Context (language use), Irinotecan, Nonlinear mixed effect modelling, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Pharmacokinetics, Internal medicine, medicine, Humans, education, Pharmacology, business.industry, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, stomatognathic diseases, 030104 developmental biology, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Camptothecin, Topoisomerase I Inhibitors, business
وصف الملف: application/pdf
-
3
المؤلفون: Patrick M. Boland, Christos Fountzilas, Marwan Fakih, Mateusz Opyrchal, Jennifer R. Diamond, Bradley Corr, Wen Wee Ma, Michelle Redman, Wing-Kai Chan, Hui Wang, Doug Kramer, Rudolf Kwan, David Cutler, Jay Zhi, Antonio Jimeno
المصدر: Cancer chemotherapy and pharmacology. 90(2)
مصطلحات موضوعية: Pharmacology, Mesylates, Cancer Research, Oncology, Maximum Tolerated Dose, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Pharmacology (medical), Camptothecin, Topoisomerase I Inhibitors, Toxicology, Irinotecan
-
4
المؤلفون: Guangxuan Liu, Yingjie Qi
المصدر: Drug Delivery, Vol 28, Iss 1, Pp 171-182 (2021)
Drug Delivery
article-version (VoR) Version of Recordمصطلحات موضوعية: Carcinoma, Hepatocellular, Berberine, Mice, Nude, Pharmaceutical Science, RM1-950, 02 engineering and technology, Topoisomerase-I Inhibitor, 030226 pharmacology & pharmacy, Microsphere, liver cancer, Mice, 03 medical and health sciences, chemistry.chemical_compound, Drug Delivery Systems, 0302 clinical medicine, Cell Line, Tumor, medicine, Animals, Humans, lipid microsphere, biology, Chemistry, Topoisomerase, Liver Neoplasms, synergistic treatment, General Medicine, Hypoxia-Inducible Factor 1, alpha Subunit, bbr, 021001 nanoscience & nanotechnology, medicine.disease, Antineoplastic Agents, Phytogenic, Xenograft Model Antitumor Assays, Microspheres, Rats, Drug Liberation, 10-hcpt, Cancer research, biology.protein, Camptothecin, Therapeutics. Pharmacology, Topoisomerase I Inhibitors, 0210 nano-technology, Liver cancer, Research Article
-
5
المؤلفون: Xiaoxia Yang, Steven Fletcher, Noriko Yanaba, John S. Allen, Julie Ritchey, Julie O'Neal, Grace Cui, Ravi Vij, Mark A. Fiala, Anne H. Schmieder-Atteberry, Kathleen Simons, Francesca Fontana, Michael J. Scott, John F. DiPersio, Dipanjan Pan, Michael P. Rettig, Gregory M. Lanza
المصدر: Clin Cancer Res
مصطلحات موضوعية: 0301 basic medicine, Melphalan, Cancer Research, medicine.medical_treatment, Drug resistance, Integrin alpha4beta1, Dexamethasone, Article, Mice, 03 medical and health sciences, 0302 clinical medicine, In vivo, hemic and lymphatic diseases, Cell Line, Tumor, Cell Adhesion, medicine, Animals, Humans, Multiple myeloma, Chemotherapy, business.industry, Cancer, Prodrug, medicine.disease, Mice, Inbred C57BL, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, Nanoparticles, Camptothecin, Topoisomerase I Inhibitors, Multiple Myeloma, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aff6d0fcdbbb3dfbe4efcc0a6040901
https://doi.org/10.1158/1078-0432.ccr-20-2839 -
6
المؤلفون: Bong Seog Kim, Heung Tae Kim, Sang We Kim, Joo Hang Kim, Joung Soon Jang, Dong Wan Kim, Ki Hyeong Lee, Jin-Soo Kim, Ho Jung An, Jin Hyoung Kang, Hye Ryun Kim, Jin-Hyuk Choi
المصدر: British Journal of Cancer
مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Article, Small-cell lung cancer, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Clinical endpoint, Humans, Infusions, Intravenous, Lung cancer, Aged, business.industry, Middle Aged, Prognosis, medicine.disease, Small Cell Lung Carcinoma, Clinical trial, Tolerability, 030220 oncology & carcinogenesis, Toxicity, Camptothecin, Female, Topotecan, Neoplasm Recurrence, Local, Topoisomerase I Inhibitors, business, medicine.drug
-
7
المؤلفون: Linda Sciuto, Yves Pommier, Cody J. Peer, William D. Figg, Thomas P. C. Dorlo, Lisa M. Cordes, Anish Thomas, Susan Wroblewski, Alwin D. R. Huitema, Keith T. Schmidt, Ravi A. Madan
المصدر: Cancer Chemotherapy and Pharmacology
مصطلحات موضوعية: Male, Cancer Research, Population, Phases of clinical research, Pharmacology, Toxicology, Models, Biological, Piperazines, Nanoparticle, Pharmacokinetics, NLMEM, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Nitriles, Phenylthiohydantoin, medicine, Distribution (pharmacology), Humans, Pharmacology (medical), Population pharmacokinetics, education, Aged, Neoplasm Staging, education.field_of_study, Cyclodextrins, Chemistry, Drug release, Middle Aged, Pharmacokinetic analysis, Topoisomerase I, Drug Liberation, Oncology, Benzamides, Phthalazines, Original Article, Camptothecin, Female, Topoisomerase I Inhibitors, medicine.drug, Clearance, Conjugate, Half-Life
-
8
المؤلفون: Masato Murakami, Taisei Nomura, Tomomichi Ishizaka, Naoyuki Maeda, Ichiro Hayakawa, Kenji Hirotani, Manabu Abe, Tsuyoshi Karibe, Akiko Zembutsu, Yusuke Ogitani, Yuuri Hashimoto, Koji Morita, Takashi Nakada, Yuki Abe, Kenichi Wakita, Yoshinobu Shiose, Takashi Kagari, Kumiko Koyama, Yasuki Kamai, Takuma Iguchi, Toshinori Agatsuma, Suguru Ueno, Yuki Kaneda
المصدر: Clinical Cancer Research. 25:7151-7161
مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Patritumab, Antibody-drug conjugate, Immunoconjugates, Receptor, ErbB-3, media_common.quotation_subject, Mice, Nude, Apoptosis, Antibodies, Monoclonal, Humanized, Mice, 03 medical and health sciences, chemistry.chemical_compound, Drug Delivery Systems, 0302 clinical medicine, Mice, Inbred NOD, Neoplasms, Tumor Cells, Cultured, Animals, Humans, Cytotoxic T cell, Exatecan, skin and connective tissue diseases, Internalization, Cell Proliferation, media_common, Cell growth, Chemistry, Xenograft Model Antitumor Assays, Rats, Gene Expression Regulation, Neoplastic, body regions, Macaca fascicularis, 030104 developmental biology, Oncology, Targeted drug delivery, 030220 oncology & carcinogenesis, Cancer cell, Cancer research, Camptothecin, Topoisomerase I Inhibitors
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3afa8d4ab9bede91d40886d7b382e7
https://doi.org/10.1158/1078-0432.ccr-19-1745 -
9
المؤلفون: L. Piazza, C. Contin-Bordes, L. Tran, F. Bonnet, J. Lapoirie, M. E. Truchetet
المساهمون: Hôpital Saint-André, CHU Bordeaux [Bordeaux], Aquitaine Sciences Transfert, Immunology from Concept and Experiments to Translation (ImmunoConcept), Centre National de la Recherche Scientifique (CNRS)-Université de Bordeaux (UB), Hôpital Pellegrin, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Bordeaux
المصدر: Scientific Reports
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.18011. ⟨10.1038/s41598-021-97538-3⟩
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)مصطلحات موضوعية: MMP1, Metabolite, Pathogenesis, chemistry.chemical_compound, 0302 clinical medicine, Fibrosis, skin and connective tissue diseases, Chemokine CCL2, Skin, Multidisciplinary, integumentary system, Connective tissue disease, 3. Good health, 030220 oncology & carcinogenesis, Medicine, Matrix Metalloproteinase 1, Procollagen, medicine.drug, Cell biology, Science, Immunology, Primary Cell Culture, Irinotecan, Article, Collagen Type I, 03 medical and health sciences, Medical research, Rheumatology, medicine, Humans, RNA, Messenger, Active metabolite, 030203 arthritis & rheumatology, Scleroderma, Systemic, business.industry, Gene Expression Profiling, Fibroblasts, medicine.disease, Actins, Collagen Type I, alpha 1 Chain, Gene Expression Regulation, chemistry, Case-Control Studies, Cancer research, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Topoisomerase I Inhibitors, business, Camptothecin
وصف الملف: application/pdf
-
10
المؤلفون: Xiang Lin Yuan, Kei Muro, Satoshi Morita, Masahito Kotaka, Keun Wook Lee, Joong Bae Ahn, Sang-Hee Cho, Young Suk Park, Dong Sheng Zhang, Tomohiro Nishina, Wei Jia Fang, Ying Yuan, Hiroshi Matsuoka, Masato Nakamura, Satoru Iwasa, Li Bai, Yong Sang Hong, Junichi Sakamoto, Sae-Won Han, Tae Won Kim, Yasuhide Yamada
المصدر: Cancer Science
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Bevacizumab, Genotype, Colorectal cancer, Leucovorin, colorectal cancer, Gastroenterology, Deoxycytidine, Capecitabine, Young Adult, Clinical Research, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Confidence Intervals, Humans, Glucuronosyltransferase, XELIRI, irinotecan, Aged, Aged, 80 and over, business.industry, capecitabine, Hazard ratio, General Medicine, Original Articles, Middle Aged, medicine.disease, Prognosis, Progression-Free Survival, Irinotecan, Treatment Outcome, Oncology, Fluorouracil, FOLFIRI, Camptothecin, Female, Original Article, UGT1A1, Topoisomerase I Inhibitors, business, Colorectal Neoplasms, medicine.drug